Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,466,230
  • Shares Outstanding, K 98,277
  • Annual Sales, $ 1,902 M
  • Annual Income, $ 235,240 K
  • EBIT $ -115 M
  • EBITDA $ -117 M
  • 60-Month Beta 0.85
  • Price/Sales 1.85
  • Price/Cash Flow 14.67
  • Price/Book 3.07

Options Overview Details

View History
  • Implied Volatility 78.67% ( -1.29%)
  • Historical Volatility 128.44%
  • IV Percentile 85%
  • IV Rank 40.33%
  • IV High 147.45% on 05/29/24
  • IV Low 32.18% on 01/22/25
  • Put/Call Vol Ratio 0.64
  • Today's Volume 4,776
  • Volume Avg (30-Day) 9,399
  • Put/Call OI Ratio 0.55
  • Today's Open Interest 127,766
  • Open Int (30-Day) 86,616

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.38
  • Number of Estimates 5
  • High Estimate 1.13
  • Low Estimate -0.55
  • Prior Year 0.07
  • Growth Rate Est. (year over year) +442.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.10 +6.83%
on 05/15/25
64.80 -43.78%
on 05/05/25
-17.51 (-32.46%)
since 04/16/25
3-Month
34.10 +6.83%
on 05/15/25
110.00 -66.88%
on 02/21/25
-71.52 (-66.25%)
since 02/14/25
52-Week
34.10 +6.83%
on 05/15/25
173.25 -78.97%
on 06/21/24
-96.31 (-72.56%)
since 05/16/24

Most Recent Stories

More News
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore

These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next

KRYS : 130.60 (+0.21%)
SRPT : 36.43 (+3.29%)
LNTH : 81.24 (+1.83%)
2 Stocks Near Their 52-Week Lows That Still Aren't Worth Buying

SRPT : 36.43 (+3.29%)
TLRY : 0.4950 (+12.50%)
Stocks Finish Higher as Chip Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. June E-mini S&P...

GOOGL : 166.19 (+1.36%)
ANET : 96.42 (+0.36%)
AVGO : 228.61 (-1.73%)
SRPT : 36.43 (+3.29%)
ADI : 227.11 (unch)
TXN : 188.50 (+0.36%)
$IUXX : 21,427.94 (+0.43%)
ASML : 748.10 (-1.35%)
ZNM25 : 110-105s (+0.07%)
ESM25 : 5,975.50s (+0.71%)
QCOM : 152.50 (-0.07%)
GFS : 39.54 (unch)
Stocks Turn Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. June E-mini S&P futures (ESM25...

ANET : 96.42 (+0.36%)
CRWD : 439.26 (+1.72%)
SRPT : 36.43 (+3.29%)
$SPX : 5,958.38 (+0.70%)
SMCI : 46.15 (+4.98%)
COR : 290.22 (+1.68%)
$IUXX : 21,427.94 (+0.43%)
NQM25 : 21,506.00s (+0.49%)
ROK : 309.05 (+0.39%)
DIS : 113.42 (+1.07%)
QQQ : 521.51 (+0.44%)
ZNM25 : 110-105s (+0.07%)
Stocks Boosted as US and China Agree to Begin Trade Talks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.12%. June E-mini S&P futures (ESM25...

ANET : 96.42 (+0.36%)
CRWD : 439.26 (+1.72%)
SRPT : 36.43 (+3.29%)
$SPX : 5,958.38 (+0.70%)
SMCI : 46.15 (+4.98%)
$IUXX : 21,427.94 (+0.43%)
NQM25 : 21,506.00s (+0.49%)
ROK : 309.05 (+0.39%)
DIS : 113.42 (+1.07%)
QQQ : 521.51 (+0.44%)
ZNM25 : 110-105s (+0.07%)
ESM25 : 5,975.50s (+0.71%)
Stock Index Futures Climb on U.S.-China Trade Talk Optimism, Fed Rate Decision in Focus

June S&P 500 E-Mini futures (ESM25) are up +0.58%, and June Nasdaq 100 E-Mini futures (NQM25) are up +0.64% this morning as optimism around U.S.-China trade talks boosted sentiment.

APP : 362.34 (-1.16%)
SRPT : 36.43 (+3.29%)
HON : 222.88 (+0.27%)
SMCI : 46.15 (+4.98%)
VRTX : 438.65 (+0.98%)
UPWK : 17.24 (+0.88%)
AMBUB.C.DX : 105.400 (+3.59%)
DIS : 113.42 (+1.07%)
ESM25 : 5,975.50s (+0.71%)
MELI : 2,584.92 (-0.06%)
NOVOB.C.DX : 426.400 (-1.66%)
FTNT : 104.59 (+1.98%)
Sarepta Therapeutics: Q1 Earnings Snapshot

Sarepta Therapeutics: Q1 Earnings Snapshot

SRPT : 36.43 (+3.29%)
1 of Wall Street’s Favorite Stock on Our Buy List and 2 to Approach with Caution

1 of Wall Street’s Favorite Stock on Our Buy List and 2 to Approach with Caution

SRPT : 36.43 (+3.29%)
VRT : 106.04 (+0.63%)
BASE : 18.77 (+2.74%)
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

SRPT : 36.43 (+3.29%)
BMRN : 59.27 (+1.72%)
ABBV : 184.02 (+1.29%)
MRNA : 24.86 (+5.12%)
AMGN : 272.41 (+0.27%)
Can Solid Biosciences Challenge Sarepta in the DMD Market?

Solid Biosciences' Duchenne muscular dystrophy (DMD) drug could provide superior outcomes compared to an already approved medication projected to make billions.

SLDB : 2.77 (+6.95%)
SRPT : 36.43 (+3.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 38.49
2nd Resistance Point 37.60
1st Resistance Point 37.02
Last Price 36.43
1st Support Level 35.55
2nd Support Level 34.66
3rd Support Level 34.08

See More

52-Week High 173.25
Fibonacci 61.8% 120.09
Fibonacci 50% 103.68
Fibonacci 38.2% 87.26
Last Price 36.43
52-Week Low 34.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »